Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia

Blood Cancer J. 2011 Jun;1(6):e22. doi: 10.1038/bcj.2011.20. Epub 2011 Jun 10.
No abstract available